Harmony Biosciences Holdings (HRMY) Equity Ratio (2019 - 2025)
Historic Equity Ratio for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to 0.69.
- Harmony Biosciences Holdings' Equity Ratio rose 749.41% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year increase of 749.41%. This contributed to the annual value of 0.66 for FY2024, which is 1462.69% up from last year.
- Per Harmony Biosciences Holdings' latest filing, its Equity Ratio stood at 0.69 for Q3 2025, which was up 749.41% from 0.7 recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Equity Ratio registered a high of 0.7 during Q2 2025, and its lowest value of 0.32 during Q1 2021.
- Over the past 5 years, Harmony Biosciences Holdings' median Equity Ratio value was 0.61 (recorded in 2024), while the average stood at 0.56.
- In the last 5 years, Harmony Biosciences Holdings' Equity Ratio surged by 8909.91% in 2021 and then tumbled by 372.92% in 2023.
- Over the past 5 years, Harmony Biosciences Holdings' Equity Ratio (Quarter) stood at 0.43 in 2021, then skyrocketed by 38.93% to 0.6 in 2022, then dropped by 3.73% to 0.58 in 2023, then rose by 14.63% to 0.66 in 2024, then grew by 4.78% to 0.69 in 2025.
- Its last three reported values are 0.69 in Q3 2025, 0.7 for Q2 2025, and 0.68 during Q1 2025.